This investment coincides with China’s burgeoning presence in the pharmaceutical industry, driven by an uptick in innovative ...

AstraZeneca has unveiled plans to invest $15bn (£11bn) in China just months after dropping hundreds of millions of pounds of ...

By Andrew MacAskill and Maggie Fick BEIJING/LONDON, Jan 29 (Reuters) - UK drugmaker AstraZeneca will invest $15 billion in ...

Keir Starmer says the move, announced during his trip to Beijing, will help support thousands of British jobs ...

British pharmaceutical group AstraZeneca said Thursday that it would invest $15 billion in China through 2030 to expand its ...

AstraZeneca has outlined plans to invest $15 billion in China through 2030, making a broad commitment to the country to ...

The drug maker says the funding will expand medicines production and research capabilities, as London and Beijing seek to ...

AstraZeneca has announced a $15bn investment in China by 2030 to expand manufacturing and R&D.

The UK-based multinational, science-led biopharmaceutical company AstraZeneca on Thursday announced $15 billion investment in ...

The plan to unveil AstraZeneca's China manufacturing and research expansion was made during Prime Minister Keir Starmer's ...

AstraZeneca announces a $15B China investment through 2030 to expand manufacturing and R&D in cell therapy and ...

AstraZeneca has announced a $15 billion investment in China through 2030 to expand medicines manufacturing and R&D.